0
13
Journal Articles about Antipsychotics Showing 161-180 of 931
Reviews and Overviews | February 01, 2002
Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials
Stefan Leucht, M.D.; Gabi Pitschel-Walz, Ph.D.; Rolf R. Engel, Ph.D.; Werner Kissling, M.D.
The American Journal of Psychiatry. 2002 February ; 2(159):180-190
PDFPDF
Brief Report | January 01, 2002
High Choline Concentrations in the Caudate Nucleus in Antipsychotic-Naive Patients With Schizophrenia
Juan R. Bustillo, M.D.; Laura M. Rowland, M.A.; John Lauriello, M.D.; Helen Petropoulos, B.E.; Roger Hammond, M.D.; Blaine Hart, M.D.; William M. Brooks, Ph.D.
The American Journal of Psychiatry. 2002 January ; 1(159):130-133
PDFPDF
Brief Report | January 01, 2002
Elevation of Prolactin Levels by Atypical Antipsychotics
Peter Turrone, B.A.(Sp.H.), M.Sc.; Shitij Kapur, M.D., Ph.D., F.R.C.P.C.; Mary V. Seeman, M.D., F.R.C.P.C.; Alastair J. Flint, M.D., F.R.C.P.C.
The American Journal of Psychiatry. 2002 January ; 1(159):133-135
PDFPDF
Brief Report | January 01, 2002
Use of Atypical Antipsychotics During Pregnancy and the Risk of Neural Tube Defects in Infants
Gideon Koren, M.D., F.A.C.M.T., F.R.C.P.C.; Tony Cohn, M.B., Ch.B.; David Chitayat, M.D., F.R.C.P.C.; Bhushan Kapur, Ph.D.; Gary Remington, M.D., Ph.D.; Diane Myles Reid, M.Sc.; Robert B. Zipursky, M.D., F.R.C.P.C.
The American Journal of Psychiatry. 2002 January ; 1(159):136-137
PDFPDF
Article | January 01, 2002
Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?
Christian R. Dolder, Pharm.D.; Jonathan P. Lacro, Pharm.D.; Laura B. Dunn, M.D.; Dilip V. Jeste, M.D.
The American Journal of Psychiatry. 2002 January ; 1(159):103-108
PDFPDF
Article | January 01, 2002
EEG Abnormalities During Treatment With Typical and Atypical Antipsychotics
Franca Centorrino, M.D.; Bruce H. Price, M.D.; Margaret Tuttle, M.S.; Won-Myong Bahk, M.D., Ph.D.; John Hennen, Ph.D.; Matthew J. Albert, B.A.; Ross J. Baldessarini, M.D.
The American Journal of Psychiatry. 2002 January ; 1(159):109-115
PDFPDF
Article | November 01, 2001
Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Michael Gitlin, M.D.; Keith Nuechterlein, Ph.D.; Kenneth L. Subotnik, Ph.D.; Joseph Ventura, Ph.D.; Jim Mintz, Ph.D.; David L. Fogelson, M.D.; George Bartzokis, M.D.; Manickam Aravagiri, Ph.D.
The American Journal of Psychiatry. 2001 November ; 11(158):1835-1842
PDFPDF
Reviews and Overviews | November 01, 2001
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Alexander H. Glassman, M.D.; J. Thomas Bigger, Jr., M.D.
The American Journal of Psychiatry. 2001 November ; 11(158):1774-1782
PDFPDF
Brief Report | October 01, 2001
Association of the TaqI A Polymorphism of the Dopamine D2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome
Akihito Suzuki, M.D., Ph.D.; Tsuyoshi Kondo, M.D., Ph.D.; Koichi Otani, M.D., Ph.D.; Kazuo Mihara, M.D., Ph.D.; Norio Yasui-Furukori, M.D., Ph.D.; Akira Sano, M.D., Ph.D.; Kazuko Koshiro, M.D., Ph.D.; Sunao Kaneko, M.D., Ph.D.
The American Journal of Psychiatry. 2001 October ; 10(158):1714-1716
PDFPDF
Brief Report | October 01, 2001
Association of Olanzapine-Induced Weight Gain With an Increase in Body Fat
Ursula Eder, M.D.; Barbara Mangweth, Ph.D.; Christoph Ebenbichler, M.D.; Elisabeth Weiss, M.D.; Alex Hofer, M.D.; Martina Hummer, M.D.; Georg Kemmler, Ph.D.; Monika Lechleitner, M.D.; W. Wolfgang Fleischhacker, M.D.
The American Journal of Psychiatry. 2001 October ; 10(158):1719-1722
PDFPDF
Brief Report | October 01, 2001
Enhancement of Cognitive Performance in Schizophrenia by Addition of Tandospirone to Neuroleptic Treatment
Tomiki Sumiyoshi, M.D., Ph.D.; Mié Matsui, Ph.D.; Shigeru Nohara, M.D., Ph.D.; Ikiko Yamashita, M.Ed.; Masayoshi Kurachi, M.D., Ph.D.; Chika Sumiyoshi, Ph.D.; Karu Jayathilake, Ph.D.; Herbert Y. Meltzer, M.D.
The American Journal of Psychiatry. 2001 October ; 10(158):1722-1725
PDFPDF
Article | September 01, 2001
Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Clinical Trials: An Analysis of the Food and Drug Administration Database
Arif Khan, M.D.; Shirin R. Khan; Robyn M. Leventhal, B.A.; Walter A. Brown, M.D.
The American Journal of Psychiatry. 2001 September ; 9(158):1449-1454
PDFPDF
Reviews and Overviews | September 01, 2001
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Donald C. Goff, M.D.; Joseph T. Coyle, M.D.
The American Journal of Psychiatry. 2001 September ; 9(158):1367-1377
PDFPDF
Brief Report | July 01, 2001
Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia
Padraig Wright, M.R.C.Psych., M.D.; Martin Birkett, B.Sc.; Stacy R. David, Ph.D.; Karena Meehan, M.B., M.R.C.P., M.R.C.Psych.; Iris Ferchland, M.Sc.; Karla J. Alaka, M.M.Sc.; John C. Saunders, M.A.; John Krueger, M.B.A.; Patrice Bradley, B.S.; Luis San, M.D., Ph.D.; Miguel Bernardo, M.D., Ph.D.; Michael Reinstein, M.D.; Alan Breier, M.D.
The American Journal of Psychiatry. 2001 July ; 7(158):1149-1151
PDFPDF
Brief Report | June 01, 2001
Plasma Protein and Lipoprotein Distribution of Clozapine
Ric M. Procyshyn, Ph.D.; Nathan B. Kennedy; Samantha Marriage; Kishor M. Wasan, Ph.D.
The American Journal of Psychiatry. 2001 June ; 6(158):949-951
PDFPDF
Article | June 01, 2001
Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment
Jeremy M. Crook, Ph.D.; Eva Tomaskovic-Crook, B.Sc.(Hons.); David L. Copolov, M.B.B.S., Ph.D.; Brian Dean, Ph.D.
The American Journal of Psychiatry. 2001 June ; 6(158):918-925
PDFPDF
Article | June 01, 2001
No Support for Regional Selectivity in Clozapine-Treated Patients: A PET Study With [11C]Raclopride and [11C]FLB 457
Mirjam Talvik, M.D.; Anna-Lena Nordström, M.D., Ph.D.; Svante Nyberg, M.D., Ph.D.; Hans Olsson, M.D.; Christer Halldin, Ph.D.; Lars Farde, M.D., Ph.D.
The American Journal of Psychiatry. 2001 June ; 6(158):926-930
PDFPDF
Article | June 01, 2001
Impact of Clozapine on Completed Suicide
Michael J. Sernyak, M.D.; Rani Desai, Ph.D.; Marilyn Stolar, M.A.; Robert Rosenheck, M.D.
The American Journal of Psychiatry. 2001 June ; 6(158):931-937
PDFPDF
Article | May 01, 2001
A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder
Robert R. Conley, M.D.; Ramy Mahmoud, M.D., M.P.H.
The American Journal of Psychiatry. 2001 May ; 5(158):765-774
PDFPDF
Brief Report | May 01, 2001
Association of Short-Term Response to Haloperidol Treatment With a Polymorphism in the Dopamine D2 Receptor Gene
Martin Schäfer, M.D.; Dan Rujescu, M.D.; Ina Giegling; Axel Guntermann; Andreas Erfurth, M.D.; Brigitta Bondy, M.D.; Hans-Jürgen Möller, M.D.
The American Journal of Psychiatry. 2001 May ; 5(158):802-804
PDFPDF
Copyright ©
American
Psychiatric
Association